VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA” or the “Company”), a leading developer of next-generation antibody-based cancer therapies, today provided an update on its strategy and progress to implement ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #5 is about a biotech by the name of Cytokinetics (CYTK). The reason why I believe that it is important ...

VERAXA Biotech ( VRXA) said it is implementing FDA-aligned New Approach Methodologies (NAMs) across its preclinical research and development programs to potentially accelerate clinical advancement and ...

The next article I wanted to discuss for the Biotech Analysis Central Model 10+ Portfolio Pick #2 is about a biotech by the name of Viking Therapeutics (VKTX). The reason why I want to go over this ...

Newswise — JMIR Publications is pleased to announce a new theme issue titled “Machine Learning-Based Predictive Models Using Genomic Data” in JMIR Bioinformatics and Biotechnology. The peer-reviewed ...

INDIANAPOLIS, Sept. 9, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced the launch of Lilly TuneLab, an artificial intelligence and machine learning (AI/ML) platform that ...

Stem cell biotechnology is a field of biotechnology that develops tools and therapeutics through modification and engineering of stem cells. Stem cell biotechnology is important in regenerative ...

Biotech and pharma organizations are adopting AI at rapid pace, focusing on R&D, and precision medicine. As challenges emerge ...

NEWCASTLE, England--(BUSINESS WIRE)--Atelerix, a biotech company revolutionising cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...